A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription

被引:48
|
作者
Gartel, AL [1 ]
Najmabadi, F [1 ]
Goufman, E [1 ]
Tyner, AL [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Genet, Chicago, IL 60607 USA
关键词
p21; Ras; E2F; transient transfection; CAT assay;
D O I
10.1038/sj.onc.1203411
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently reported that E2F1 could transactivate the p21 promoter via cis-acting elements between -119 to +16 bp of the p21 gene. Here we show that activated V12-H-Ras can induce the p21 promoter through the same region of the p21 promoter by a p53-independent mechanism in NIH3T3 cells. In contrast, activated Ras was not able to induce the p21 promoter in E2F1(-/-) fibroblasts, suggesting that E2F1 is required for induction of the p21 promoter by activated Ras, Cotransfection of increasing concentrations of dominant negative E2F1 alone, or with dominant negative DP1 into NIH3T3 cells suppressed induction of the p21 promoter by activated Pas. These data suggest that p53-independent induction of the p21 promoter by activated Ras is mediated at least in part by E2F1.
引用
收藏
页码:961 / 964
页数:4
相关论文
共 50 条
  • [21] Relationship of p21 (waf1/cip1) and differentiation n chondrosarcoma cells
    Hiraoka, K
    Zenmyo, M
    Komiya, S
    Kawabata, R
    Yokouchi, M
    Suzuki, R
    Hamada, T
    Kato, S
    Nagata, K
    VIRCHOWS ARCHIV, 2002, 440 (03) : 285 - 290
  • [22] p21 (WAF1/CIP1) is required for the mitogenic response to intestinal resection
    Stern, LE
    Falcone, RA
    Kemp, CJ
    Erwin, CR
    Warner, BW
    JOURNAL OF SURGICAL RESEARCH, 2000, 90 (01) : 45 - 50
  • [23] P21 Waf1/Cip1 as a therapeutic target in breast and other cancers
    Weiss, RH
    CANCER CELL, 2003, 4 (06) : 425 - 429
  • [24] Polymorphism of the p21 (WAF1/CIP1) gene in primary gastric cancer
    Kim, YJ
    Kim, HR
    Kim, DY
    Soh, BJ
    Kim, HJ
    Kim, SK
    Kim, KG
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 683 - 687
  • [25] p21(WAF1/CIP1) and terminal differentiation control of normal epithelia
    Missero, C
    Dotto, GP
    MOLECULAR AND CELLULAR DIFFERENTIATION, 1996, 4 (01): : 1 - 16
  • [26] Prognostic implications of p21 (Waf1/Cip1) immunolocalization in multiple myeloma
    Ohata, Masahiko
    Nakamura, Shinobu
    Fujita, Hiroyuki
    Isemura, Mamoru
    BIOMEDICAL RESEARCH-TOKYO, 2005, 26 (03): : 91 - 98
  • [27] The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis
    Gartel, AL
    LEUKEMIA RESEARCH, 2005, 29 (11) : 1237 - 1238
  • [28] The role of p21 Waf1/Cip1 in large airway epithelium in smokers with and without COPD
    Chiappara, Giuseppina
    Gjomarkaj, Mark
    Virzi, Alessia
    Sciarrino, Serafina
    Ferraro, Maria
    Bruno, Andreina
    Montalbano, Angela Marina
    Vitulo, Patrizio
    Minervini, Marta Ida
    Pipitone, Loredana
    Pace, Elisabetta
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (10): : 1473 - 1481
  • [29] Proteasome-dependent regulation of p21(WAF1/CIP1) expression
    Blagosklonny, MV
    Wu, GS
    Omura, S
    ElDeiry, WS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 227 (02) : 564 - 569
  • [30] P21 (WAF1/CIP1) can inhibit cardiac myocyte apoptosis
    Wang, J
    Cakulev, IT
    Abdellatif, M
    Schneider, MD
    CIRCULATION, 2000, 102 (18) : 168 - 169